CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BIOplasma aims to develop a non-invasive method for early cancer detection using Liquid Chromatography/Mass Spectrometry with a flexible Tube Micro Plasma ionization source. This innovative approach focuses on identifying lipid biomarkers in body fluids to improve diagnostic capabilities.
Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries.
In 2015, over 8.8 million people died of cancer worldwide and the numbers are expected to rise above 13 million in 2030 .
As a consequence, development of non-invasive, fast and robust methods to detect different types of cancer in an early stage are timely. BIOplasma addresses the essential need for analytical tools that permit the diagnosis of biological tissu…
LEIBNIZ-INSTITUT FUR ANALYTISCHE WISSENSCHAFTEN-ISAS-EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
